PolTREG CEO Trzonkowski co-authors peer-reviewed article showing scientific progress in T-reg autoimmune therapy
30.01.2024 - Gdańsk, Poland – 30 January 2024 – PolTREG S.A. (Warsaw Stock Exchange: PTG) , a clinical-stage biotechnology company developing cell therapies for a wide range of autoimmune diseases, announced that Prof. Piotr Trzonkowski, CEO, ... Seite 1
Anke Fuchs Natalia Marek Trzonkowska Piotr Trzonkowski Technical University Of Dresden Poltreg Sa Warsaw Stock Exchange University Of Gda
Source: wallstreet-online.de